Clinical Study

Characteristics and Patterns of Metastatic Disease from Chordoma

Table 2

Survival distribution stratified by presence of metastatic disease.
(a) Case processing summary of patients included in analysis

MetastasisTotal of eventsCensored
Percent

No150638758.0%
Yes2722518.5%

Overall177859252.0%

(b) Overall statistical comparison and test of equality of survival distributions

Chi-SquaredfSig.

Log rank (Mantel-Cox)3.68210.055

(c) Means and medians for survival time. Estimation is limited to the largest survival time if it is censored

MetastasisMeanMedian
95% Conf. interval95% Conf. interval
EstimateStd. errorLower boundUpper boundEstimateStd. errorLower boundUpper bound

No188.513.9161.3215.6159.318.1123.9194.6
Yes134.220.693.8174.6130.49.7111.4149.5

Overall177.812.5153.3202.2140.512.7115.7165.3